STEADY-STATE PHARMACOKINETICS OF 2 FORMULATIONS AND DOSAGE REGIMES OF ORAL DISOPYRAMIDE

被引：0
|
作者：
TORSTENSSON, I [1 ]
HOFVENDAHL, S [1 ]
机构：
[1] CENT HOSP,DEPT MED,HELSINGBORG,SWEDEN
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1982年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：617 / 624
页数：8
相关论文
共 50 条
  • [1] MEDROXYPROGESTERONE ACETATE - STEADY-STATE PHARMACOKINETICS BIOEQUIVANCE OF 2 ORAL FORMULATIONS
    POLLOW, K
    KREIENBERG, R
    DIPIETRO, N
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (04) : 397 - 399
  • [2] PHARMACOKINETICS AND STEADY-STATE MYOCARDIAL UPTAKE OF DISOPYRAMIDE IN DOG
    KARIM, A
    KOOK, C
    NOVOTNEY, RL
    ZAGARELLA, J
    CAMPION, J
    [J]. DRUG METABOLISM AND DISPOSITION, 1978, 6 (03) : 338 - 345
  • [3] PHARMACOKINETICS OF 2 DOSAGE LEVELS OF TRIMETHOPRIM TO STEADY-STATE IN NORMAL VOLUNTEERS
    WATSON, ID
    STEWART, MJ
    WILES, A
    MCINTOSH, SJ
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1983, 11 (03) : 137 - 144
  • [4] STEADY-STATE DOSAGE REGIMEN CALCULATIONS IN LINEAR PHARMACOKINETICS
    ILIADIS, A
    BRUNO, R
    CANO, JP
    [J]. INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING, 1986, 18 (3-4): : 167 - 182
  • [5] COMPARISON OF STEADY-STATE PHARMACOKINETICS OF 2 DOSAGE REGIMENS OF VANCOMYCIN IN NORMAL VOLUNTEERS
    HEALY, DP
    POLK, RE
    GARSON, ML
    ROCK, DT
    COMSTOCK, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) : 393 - 397
  • [6] CLINICAL PHARMACOKINETICS OF LEVOROTATORY AND RACEMIC DISOPYRAMIDE, AT STEADY-STATE, FOLLOWING ORAL-ADMINISTRATION IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
    LECORRE, P
    GIBASSIER, D
    DESCAVES, C
    SADO, P
    DAUBERT, JC
    LEVERGE, R
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (12): : 1089 - 1096
  • [7] CIRCADIAN VARIATION IN THE PHARMACOKINETICS OF ORAL KETOPROFEN AT STEADY-STATE
    ATKINSON, HC
    ROBSON, RA
    BEGG, EJ
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1990, 103 (889) : 221 - 221
  • [8] THE EFFECT OF CIRRHOSIS ON THE STEADY-STATE PHARMACOKINETICS OF ORAL CIPROFLOXACIN
    FROST, RW
    LETTIERI, JT
    KROL, G
    SHAMBLEN, EC
    LASSETER, KC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (06) : 608 - 616
  • [9] ORAL DISOPYRAMIDE DOSAGE REGIMES IN ISCHEMIC-HEART-DISEASE
    BRYSON, SM
    FOTHERINGHAM, GH
    STRUTHERS, MGB
    WHITING, B
    [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1982, 7 (01): : 37 - 42
  • [10] STEADY-STATE PHARMACOKINETICS AND BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE IN CHILDREN WITH CARDIAC-ARRHYTHMIAS
    CHIBA, K
    KOIKE, K
    NAKAMOTO, M
    ECHIZEN, H
    ISHIZAWA, A
    ISHIZAKI, T
    [J]. THERAPEUTIC DRUG MONITORING, 1992, 14 (02) : 112 - 118
12345